Primary Job Title Director of the National Biologics Manufacturing Centre Primary Organization 
Centre for Process Innovation
Location Redcar, Redcar and Cleveland, United Kingdom Regions Europe, Middle East, and Africa (EMEA) Gender Male
In April 2013, Chris was appointed in his new role as Director of CPI’s £38 million National Biologics Manufacturing Centre. The centre will help UK companies to develop new processes and products and embrace and test new and emerging technologies in the growing biopharmaceutical market.
Chris has worked at CPI as a director since the day it
began trading to helping companies and organisations test, develop and scale up sustainable processes, products and energy solutions. His practical and commercial approach enables customers to sustain competitiveness and enter valuable and new markets as quickly as possible.
In Chris’ career he has worked internationally helping companies take from laboratory concepts to world scale plant. Following his PhD at the University of Strathclyde in 1988, Chris joined ICI as a research chemist and then developed his technical career across a range of roles from separations technology through to plant operations support and then moved into new disciplines in, engineering and biotechnology. Chris has also been involved in managing GLP laboratories, moving through into commercial business development and management.. Chris has also worked for engineering and process technology licensing companies. He has sectorial experience of pharmaceuticals, chemicals, materials, and biotechnology. Some publications and patents are held, but Chris has mainly delivered process and technology packages to clients for their interpretation. Chris has presented widely at conferences and has been called on to collaborate and work on relevant themes in and for the UK’s IB-IGT, BBSRC, EIBI, Europabio, Star-COLIBRI and the ETI.
